Long-term follow-up of hepatitis C virus infection among organ transplant recipients: Implications for policies on organ procurement

Transplantation

Volumn 63, Issue 6, 1997, Pages 849-853

  Bouthot, Beth A ^a   Murthy, B V R ^a   Schmid, Christopher H ^a   Levey, Andrew S ^a   Pereira, Brian J G ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS ANTIBODY;

ARTICLE; FOLLOW UP; GRAFT SURVIVAL; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION RISK; LONG TERM CARE; MAJOR CLINICAL STUDY; ORGAN TRANSPLANTATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME;

FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEART TRANSPLANTATION; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PROBABILITY; RECURRENCE; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 0030939639     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199703270-00010     Document Type: Article

References (25)

1. Pereira BJ. Hepatitis C infection and post-transplantation liver disease. [Review]. Nephrol Dial Transplant 1995; 1: 58.
2. Esteban JI, Gonzales A, Hernandez JM, et al. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 1990; 323: 1107.
3. Pereira BJG, Milford EL, Kirkman RL, Levey AS. Transmission of hepatitis C virus by organ transplantation. N Engl J Med 1991; 325: 454.
4. Pereira BJG, Milford EL, Kirkman RL, et al. Prevalence of hepatits C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. N Engl J Med 1992; 327: 910.
5. Aeder MI, Shield CF, Tegtmeier GE, et al. Incidence and clinical impact of hepatitis C virus-positive donors in cadaveric transplantation. Transplant Proc 1993; 25: 1469.
6. Cendoroglo Neto M, Manzano SI, Canziani ME, et al. Environmental transmission of hepatitis B and hepatitis C viruses within the hemodialysis unit. Artif Organs 1995; 19: 251.
7. Seeff LB, Buskell-Bales Z, Wright EC, et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis: the National Heart, Lung, and Blood Institute Study Group. N Engl J Med 1992; 327: 1906.
8. US Renal Data System. USRDS 1996 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1996.
9. Pereira BJG, Wright TL, Schmid CH, Levey AS, for the New England Organ Bank Hepatitis C Study Group. The impact of pretransplantation hepatitis C infection on the outcome of renal transplantation. Transplantation 1995; 60: 799.
10. Pereira BJG, Wright TL, Schmid CH, Levey AS, for The New England Organ Bank Hepatitis C Study Group. A controlled study of hepatitis C transmission by organ transplantation. Lancet 1995; 345: 484.
11. Kiyosawa K, Sodeyama T, Tanaka E, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671.
12. Pereira BJG, Wright TL, Schmid CH, et al. Screening and confirmatory testing of cadaver organ donors for hepatitis C virus infection: a U.S. National Collaborative Study. Kidney Int 1994; 46: 886.
13. Pereira BJG, Levey AS. Hepatitis C infection in cadaver organ donors: strategies to reduce transmission of infection and prevent organ waste. Pediatr Nephrol 1995; 9 (suppl): S23.
14. Pirsch JD, Heisey D, D'Allesandro AM, Knechtle SJ, Sollinger HW, Beizer FO. Transplantation of hepatitis C (HCV) kidneys: defining the risks. 14th Annual Meeting of the American Society of Transplant Physicians, Chicago, May 14-17, 1995.
15. Stempel CA, Lake J, Kuo G, Vincenti F. Hepatitis C: its prevalence in end-stage renal failure patients and clinical course after kidney transplantation. Transplantation 1993; 55: 273.
16. Huang C-C, Liaw Y-F, Lai M-K, et al. The clinical outcome of hepatitis C virus antibody-positive renal allograft recipients. Transplantation 1992; 53: 763.
17. Ponz E, Campistol JM, Barrera JM, et al. Hepatitis C virus antibodies in patients on hemodialysis and after transplantation. Transplant Proc 1991; 23: 1371.
18. Roth D, Zucker K, Cirocco R, et al. The impact of hepatitis C virus infection on renal allograft recipients. Kidney Int 1994; 45: 238.
19. Roth D. Hepatitis C virus: the nephrologist's view. Am J Kidney Dis 1995; 25: 3.
20. Ynares C, Johnson HK, Kerlin T, Crowe D, MacDonell R, Richie R. Impact of pre-transplant hepatitis C antibody status upon long-term patient and renal allograft survival: a 5- and 10-year follow-up. Transplant Proc 1993; 25: 1466.
21. Fritsche C, Brandes JC, Delaney SR, et al. Hepatitis C is a poor prognostic indicator in black kidney transplant recipients. Transplantation 1993; 55: 1283.
22. Morales JM, Campistol JM, Castellano G, et al. Transplantation of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCV. Kidney Int 1995; 47: 236.
23. Widell A, Mansson S, Persson NH, Thysell H, Hermodsson S, Blohme I. Hepatitis C superinfection in hepatitis C virus (HCV)-infected patients transplanted with an HCV-infected kidney. Transplantation 1995; 60: 642.
24. Oldach D, Constantine N, Schweitzer E, et al. Clinical and virological outcomes in hepatitis C virus (HCV)-infected renal transplant recipients. 14th Annual Meeting of the American Society of Transplant Physicians, Chicago, May 14-17, 1995.
25. McOmish F, Chan SW, Dow BC, et al. Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine amino-transferase abnormalities. Transfusion 1993; 33: 7.